ReviewTherapeutics and clinical risk management2022

A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease.

Zeyu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.